Business e via Italy - Menarini Group

Business e via Italy - Menarini Group, based in Florence, Italy, will acquire Stemline. It will give them a toehold in the United States, but the company also plans to continue to advance the development of its CD123-targeted therapy, Elzonris, the first ever-approved treatment for blastic plasmacytoid dendritic cell neoplasm. BPDCN is an aggressive, orphan blood disorder with historically poor outcomes. Stemline said that BPDCN can often present symptoms that can be mistaken for blood cancers, such as acute myeloid leukemia and non-Hodgkin’s lymphoma. #finance #business #madeinitaly #italy #investment #management #retail #merger #banking #setup #italian #fashion #distribution #food #automotive #industry #fashion #fashionweek #businessdevelopment #sales #internationalisation #realestate #assetmanagement #commercial #privateequity #realestate #assetmanagement #wealthmanagement

United Kingdom

5 Upper Montagu Street

London W1H 2AG

Tel +44 20 3287 2407

Company no 07022539

Italy

Via Frua 6

Milano 20146

Tel +39 02 89745 520 

P.IVA 09695750969

 

China

Chaoyang

Beijing

Tel +86 18801495721

  • LinkedIn - Black Circle
  • Black Facebook Icon
  • Black Instagram Icon

© 2020 Business e via Italy SRL